Suchergebnisse - "Wargny, Matthieu"

PubPharm (4)

1

Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function

enthalten in: Atherosclerosis | 2021

von Ramin-Mangata, S. | Thedrez, A. | Nativel, B. | +16

2

Phenotypic Differences Between Polygenic and Monogenic Hypobetalipoproteinemia

enthalten in: Arteriosclerosis, thrombosis, and vascular biology | 2021

von Rimbert, A. | Vanhoye, X. | Coulibaly, D. | +20

3

Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes

enthalten in: Atherosclerosis | 2020

von Ramin-Mangata, S. | Wargny, M. | Pichelin, M. | +9

4

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

enthalten in: Atherosclerosis | 2018

von Wargny, M. | Ducluzeau, P. | Petit, J. | +14

1
[1]